References

Hepatocellular carcinoma

10.1038/s41572-020-00240-3 · 2021 · External reference

Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy

10.1038/s41571-023-00825-3 · 2023 · External reference

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

10.1016/j.jhep.2021.11.018 · 2022 · External reference

Evolving therapeutic landscape of advanced hepatocellular carcinoma

10.1038/s41575-022-00704-9 · 2023 · External reference

Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications

10.1038/s41388-023-02702-w · 2023 · External reference

Sweet Surprises: Decoding Tumor-Associated Glycosylation in Cancer Progression and Therapeutic Potential

10.3390/cells15030233 · 2026 · External reference

The Biological Basis and Analyses of N-Glycan Microheterogeneity

10.1016/j.mcpro.2025.101491 · 2026 · External reference

Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis

10.1038/s41467-019-09222-w · 2019 · External reference

N-linked protein glycosylation in the endoplasmic reticulum

10.1101/cshperspect.a013359 · 2013 · External reference

Factors controlling the glycosylation potential of the Golgi apparatus

10.1016/s0962-8924(97)01198-7 · 1998 · External reference

Expanding N-glycopeptide identifications by modeling fragmentation, elution, and glycome connectivity

10.1038/s41467-024-50338-5 · 2024 · External reference

pGlycoQuant with a deep residual network for quantitative glycoproteomics at intact glycopeptide level

10.1038/s41467-022-35172-x · 2022 · External reference

Uncovering missing glycans and unexpected fragments with pGlycoNovo for site-specific glycosylation analysis across species

10.1038/s41467-024-52099-7 · 2024 · External reference

Precise, fast and comprehensive analysis of intact glycopeptides and modified glycans with pGlyco3

10.1038/s41592-021-01306-0 · 2021 · External reference

Decoding the glycoproteome: a new frontier for biomarker discovery in cancer

10.1186/s13045-024-01532-x · 2024 · External reference

The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States

10.1016/j.cgh.2022.01.047 · 2023 · External reference

Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma

10.1016/j.cell.2019.08.052 · 2019 · External reference

Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma

10.1038/s42255-022-00710-w · 2023 · External reference

Targeting mutant p53 for efficient cancer therapy

10.1038/nrc.2017.109 · 2018 · External reference

P2Rank: machine learning based tool for rapid and accurate prediction of ligand binding sites from protein structure

10.1186/s13321-018-0285-8 · 2018 · External reference

The role of N-glycosylation in cancer

10.1016/j.apsb.2023.10.014 · 2024 · External reference

QuPath: Open source software for digital pathology image analysis

10.1038/s41598-017-17204-5 · 2017 · External reference

A Golgi UDP-GlcNAc transporter delivers substrates for N-linked glycans and sphingolipids

10.1038/s41477-018-0235-5 · 2018 · External reference

TMEM241 is a UDP-N-acetylglucosamine transporter required for M6P modification of NPC2 and cholesterol transport

10.1016/j.jlr.2023.100465 · 2023 · External reference

Nucleotide Sugar Transporter SLC35 Family Structure and Function

10.1016/j.csbj.2019.08.002 · 2019 · External reference

Structural Characterization of Glycoprotein Glycans and Glycosaminoglycans of Brain Tissues in Slc35a3-Knockout Mice

10.3390/ijms27041643 · 2026 · External reference

Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis

10.1038/s41598-023-51028-w · 2024 · External reference